Carbazeran
CAS No. 70724-25-3
Carbazeran ( UK 31557; UK-31557; UK31557; UK 31,557; UK-31,557; UK31,557; )
Catalog No. M27410 CAS No. 70724-25-3
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 110 | Get Quote |
|
10MG | 177 | Get Quote |
|
25MG | 357 | Get Quote |
|
50MG | 530 | Get Quote |
|
100MG | 759 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCarbazeran
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
SynonymsUK 31557; UK-31557; UK31557; UK 31,557; UK-31,557; UK31,557;
-
PathwayAngiogenesis
-
TargetPDE
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number70724-25-3
-
Formula Weight360.4
-
Molecular FormulaC18H24N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCNC(=O)OC1CCN(CC1)c1nncc2cc(OC)c(OC)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jean-Louis H. Dasseux, et al. Ketone compounds and compositions for cholesterol management and related uses. WO2002030860A2.
molnova catalog
related products
-
CDP-840
CDP-840 (CDP840;L-765527) is a potent and selective PDE4 inhibitor with IC50 of 4-45 nM for PDE 4 extracted from tissues or recombinant PDE 4 isoforms expressed in yeast.
-
BRL 50481
BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.
-
Enoximone
Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.